The decision to try continuous rifaximin or add vagus nerve stimulation are two separate and discrete issues. If monthly cycles of rifaximin are not adequately controlling bacterial overgrowth, there will be little to no neurological gains after three months, and the increase to continuous rifaximin is warranted.nnThe addition of vagus nerve stimulation is based on whether or not neurological recovery occurs across all areas (speech, motor, socialization, hyperactivity, emotional regulation, etc.). If there is substantial improvement in some areas, but little to no improvement in others, then the addition of vagus nerve stimulation is warranted.

Yes, Movicol and MiraLax are both approved to be used with the protocol.

Yes, they can. Finding a gene for any particular medical condition does not mean the gene is necessarily active. A common example is that many people with brown eyes may be carrying a gene for blue eyes. They have the gene for blue eyes, but it has not been activated. I have seen a wide variety of children recovering with The Nemechek Protocol® despite tests demonstrating the presence of abnormal genes or genetic deletions.

Yes. The Nemechek Protocol for Autonomic Recovery is designed to reduce elevated levels of pro-inflammatory cytokines, and the presence of abnormally primed M1- microglia. These 2 pathological processes prevent recovery from brain injury, interfere with neuronal/synaptic pruning, interfere with brain development in utero, and are a key feature of the neurodegenerative disorders (Alzheimer’s, Parkinson’s, ALS). It is capable of reversing a wide range of chronic neurological conditions (migraine and cluster headaches, chronic fatigue, generalized anxiety, depression/PTSD, ADD/ADHD) as well as intestinal disorders (heartburn, reflux, IBS, constipation, diarrhea, etc.), and it’s potent anti-inflammatory effect substantially reduces symptoms associated with autoimmune disorders (Crohn’s, psoriasis, MS, rheumatoid arthritis, Hashimoto’s, etc.)

The Nemechek Protocol is a medical treatment program invented by Dr. Patrick M. Nemechek, D.O. relating to methods for preventing, reducing, or reversing acute and/or chronic autonomic damage by the suppression of pro-inflammatory cytokines which is useful in treating a variety of diseases or conditions (U.S. Patent No. 10,335,356).